Trend
DailyUptrend (starting)
4 hourBullish
1 hourDescending Triangle
15 minBullish
5 minConsolidating
Daily trend turns down below $362.98
Key levels
Resistance$448.54
Support$416.60
Support$397.12
Latest news & SEC filings
No headlines in the last 90 days.
Elevance Health is a health benefits company that provides managed care plans to individuals, employer groups, Medicaid and Medicare members. It operates through segments covering health benefits, pharmacy services, and care delivery, including behavioral, dental, vision, and supplemental products. The company serves members across the United States, Puerto Rico, and the District of Columbia under brands such as Anthem Blue Cross, Wellpoint, and Carelon.
Based on the company's 10-K filed Feb 6, 2026.
NYSE · Healthcare
SEPT Low Target
$395.00
SEPT Mid Target
$472.00
SEPT High Target
$523.00
Analyst Consensus
$472.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ELV.
Start Free Trial →Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$481.49
31
Moat Score
NONE
6/9
Piotroski Score
3.2
Altman Z-Score
Insider Signal
SELLING
2 buys / 13 sells (90d)
Congress Signal
BUYING
1 buys / 1 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| LAVU RATNAKAR | officer | Sale | 1,300 | $572K | Nov 5, 2026 |
| Kaye Mark | officer | Sale | 400 | $174K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 321 | $140K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 1,660 | $724K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 560 | $245K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 240 | $105K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 1,160 | $510K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 1,720 | $758K | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 2,343 | $1.0M | Oct 22, 2026 |
| Kaye Mark | officer | Sale | 480 | $212K | Oct 22, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
12.5%
3yr Revenue CAGR
8.3%
EPS Growth YoY
-1.83%
FCF Growth YoY
-30.3%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for ELV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:28:25 | $429.48 | 3,375 | $$1.4M | SELL |
| 21:00:26 | $429.48 | 1,329 | $$571K | BUY |
| 21:00:25 | $429.48 | 1,823 | $$783K | BUY |
| 21:00:19 | $429.48 | 2,079 | $$893K | SELL |
| 21:00:11 | $429.48 | 2,400 | $$1.0M | SELL |
5 dark pool trades shown · $$4.7M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for ELV, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $230 | Jan 15 | 65 | $$490 | 1 | SWEEP |
| PUT | $400 | Nov 20 | 9 | $$130 | 1 | SWEEP |
| PUT | $400 | Nov 20 | 9 | $$650 | 5 | SWEEP |
| PUT | $400 | Nov 20 | 9 | $$390 | 3 | SWEEP |
| PUT | $400 | Nov 20 | 9 | $$130 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Elevance Health, Inc. (ELV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Elevance Health, Inc. (ELV) is at $429.48, down 0.04% (-$0.17) at the Nov 11, 2026 close.
The average analyst price target for ELV is $472.00, ranging from $395 to $523, based on 13 analysts. Latest: Wells Fargo maintains on Oct 27, 2026.
Analyst ratings for ELV: 3 Buy, 33 Hold, 0 Sell — consensus Hold.
ELV last reported on Oct 21, 2026: EPS $6.99 vs $4.71 expected — a beat of 48.4%.
ELV trades at a P/E of 18.2 vs a Healthcare average of 17.3.
Yes. ELV's dividend yield is 1.97%.
Elevance Health, Inc. reported $30.8B of debt and $10.3B of cash (Sep 30, 2026).
Support: $416.60, $397.12, $375.74. Resistance: $448.54.
Insider activity: SELLING, 2 buys and 13 sells in the last 90 days.